Vycor Medical, Inc. (VYCO)
USD 0.07
(24.05%)
USD 0.07
(24.05%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.46 Million USD | 19.43% |
| 2022 | 1.22 Million USD | -12.2% |
| 2021 | 1.39 Million USD | 21.97% |
| 2020 | 1.14 Million USD | -22.93% |
| 2019 | 1.48 Million USD | -1.83% |
| 2018 | 1.5 Million USD | 8.98% |
| 2017 | 1.38 Million USD | -4.66% |
| 2016 | 1.45 Million USD | 27.58% |
| 2015 | 1.13 Million USD | -8.93% |
| 2014 | 1.25 Million USD | 14.77% |
| 2013 | 1.08 Million USD | -9.62% |
| 2012 | 1.2 Million USD | 24.08% |
| 2011 | 971.36 Thousand USD | 206.96% |
| 2010 | 316.45 Thousand USD | 58.98% |
| 2009 | 199.04 Thousand USD | 53.17% |
| 2008 | 129.94 Thousand USD | 4966.16% |
| 2007 | 2565.00 USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 336.96 Thousand USD | 9.32% |
| 2024 Q2 | 406.27 Thousand USD | 20.57% |
| 2023 Q4 | 308.24 Thousand USD | -0.11% |
| 2023 Q1 | 360.99 Thousand USD | 33.08% |
| 2023 Q2 | 482.76 Thousand USD | 33.73% |
| 2023 Q3 | 308.59 Thousand USD | -36.08% |
| 2023 FY | 1.46 Million USD | 19.43% |
| 2022 FY | 1.22 Million USD | -12.2% |
| 2022 Q1 | 313.83 Thousand USD | 14.65% |
| 2022 Q2 | 327.92 Thousand USD | 4.49% |
| 2022 Q3 | 309.96 Thousand USD | -5.48% |
| 2022 Q4 | 271.26 Thousand USD | -12.49% |
| 2021 FY | 1.39 Million USD | 21.97% |
| 2021 Q3 | 332.08 Thousand USD | -32.42% |
| 2021 Q4 | 273.72 Thousand USD | -17.57% |
| 2021 Q2 | 491.42 Thousand USD | 66.16% |
| 2021 Q1 | 295.74 Thousand USD | 1.42% |
| 2020 Q3 | 275.92 Thousand USD | 12.96% |
| 2020 Q1 | 351.05 Thousand USD | -1.08% |
| 2020 Q2 | 244.26 Thousand USD | -30.42% |
| 2020 Q4 | 291.61 Thousand USD | 5.69% |
| 2020 FY | 1.14 Million USD | -22.93% |
| 2019 Q3 | 346.3 Thousand USD | -19.44% |
| 2019 FY | 1.48 Million USD | -1.83% |
| 2019 Q1 | 350.66 Thousand USD | -17.75% |
| 2019 Q2 | 429.89 Thousand USD | 22.59% |
| 2019 Q4 | 354.88 Thousand USD | 2.48% |
| 2018 Q1 | 325.1 Thousand USD | 20.49% |
| 2018 FY | 1.5 Million USD | 8.98% |
| 2018 Q2 | 301.66 Thousand USD | -7.21% |
| 2018 Q4 | 426.35 Thousand USD | -6.55% |
| 2018 Q3 | 456.21 Thousand USD | 51.23% |
| 2017 Q3 | 379.07 Thousand USD | 23.2% |
| 2017 FY | 1.38 Million USD | -4.66% |
| 2017 Q4 | 269.81 Thousand USD | -28.82% |
| 2017 Q2 | 307.68 Thousand USD | -28.18% |
| 2017 Q1 | 428.39 Thousand USD | 23.3% |
| 2016 FY | 1.45 Million USD | 27.58% |
| 2016 Q4 | 347.44 Thousand USD | 6.65% |
| 2016 Q1 | 400.08 Thousand USD | 42.28% |
| 2016 Q3 | 325.77 Thousand USD | -14.13% |
| 2016 Q2 | 379.4 Thousand USD | -5.17% |
| 2015 Q1 | 328.55 Thousand USD | 26.71% |
| 2015 FY | 1.13 Million USD | -8.93% |
| 2015 Q3 | 242.86 Thousand USD | -15.09% |
| 2015 Q2 | 286.01 Thousand USD | -12.95% |
| 2015 Q4 | 281.2 Thousand USD | 15.79% |
| 2014 Q2 | 298.54 Thousand USD | -16.64% |
| 2014 Q4 | 259.29 Thousand USD | -22.45% |
| 2014 Q3 | 334.33 Thousand USD | 11.99% |
| 2014 Q1 | 358.12 Thousand USD | 18.93% |
| 2014 FY | 1.25 Million USD | 14.77% |
| 2013 Q2 | 234.95 Thousand USD | 1.42% |
| 2013 Q4 | 301.11 Thousand USD | -6.38% |
| 2013 Q3 | 321.63 Thousand USD | 36.89% |
| 2013 Q1 | 231.67 Thousand USD | -19.32% |
| 2013 FY | 1.08 Million USD | -9.62% |
| 2012 Q3 | 220.12 Thousand USD | -17.06% |
| 2012 Q2 | 265.38 Thousand USD | -38.65% |
| 2012 Q4 | 287.15 Thousand USD | 30.45% |
| 2012 Q1 | 432.6 Thousand USD | -4.43% |
| 2012 FY | 1.2 Million USD | 24.08% |
| 2011 Q1 | 145.12 Thousand USD | 36.72% |
| 2011 Q2 | 142.33 Thousand USD | -1.92% |
| 2011 Q3 | 231.27 Thousand USD | 62.49% |
| 2011 Q4 | 452.63 Thousand USD | 95.71% |
| 2011 FY | 971.36 Thousand USD | 206.96% |
| 2010 Q3 | 71.2 Thousand USD | -4.83% |
| 2010 Q2 | 74.81 Thousand USD | 16.38% |
| 2010 Q1 | 64.28 Thousand USD | 51.4% |
| 2010 FY | 316.45 Thousand USD | 58.98% |
| 2010 Q4 | 106.14 Thousand USD | 49.07% |
| 2009 FY | 199.04 Thousand USD | 53.17% |
| 2009 Q2 | 42.3 Thousand USD | -39.65% |
| 2009 Q3 | 44.19 Thousand USD | 4.48% |
| 2009 Q1 | 70.08 Thousand USD | -44.64% |
| 2009 Q4 | 42.45 Thousand USD | -3.93% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q4 | 126.6 Thousand USD | 3688.3% |
| 2008 Q3 | 3342.00 USD | 0.0% |
| 2008 FY | 129.94 Thousand USD | 4966.16% |
| 2008 Q2 | - USD | 0.0% |
| 2007 FY | 2565.00 USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 714.7 Thousand USD | -104.364% |
| IR-Med Inc. | - USD | -Infinity% |
| Polarean Imaging plc | 890.93 Thousand USD | -63.941% |
| Medical Supply International USA, Inc. | 2.81 Million USD | 48.157% |
| Avitar, Inc. | 3.1 Million USD | 52.978% |
| AVITA Medical, Inc. | 50.56 Million USD | 97.111% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 785.68 Million USD | 99.814% |
| Zecotek Photonics Inc. | 86.61 Thousand USD | -1586.415% |
| QHSLab, Inc. | 1.4 Million USD | -3.663% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 785.68 Million USD | 99.814% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 52.61 Million USD | 97.224% |
| Escalon Medical Corp. | 11.98 Million USD | 87.81% |
| Aurora Spine Corporation | 14.52 Million USD | 89.941% |
| BrainsWay Ltd. | 31.78 Million USD | 95.405% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 257.39 Thousand USD | -467.447% |
| Hamilton Thorne Ltd. | 68.45 Million USD | 97.866% |
| Vivos Inc. | 19.5 Thousand USD | -7390.277% |
| MicroPort Scientific Corporation | 950.72 Million USD | 99.846% |
| Kelyniam Global, Inc. | 2.67 Million USD | 45.344% |
| REMSleep Holdings, Inc. | 203.71 Thousand USD | -616.973% |
| CYduct Diagnostics, Inc. | 84.48 Thousand USD | -1628.853% |
| Nanomix Corporation | 15.45 Thousand USD | -9353.748% |
| Theraclion SA | 1.82 Million USD | 19.845% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 661.55 Thousand USD | -120.785% |
| Positron Corporation | 734.66 Thousand USD | -98.812% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.34 Million USD | -8.289% |
| Lombard Medical, Inc. | 12.16 Million USD | 87.997% |
| ALR Technologies Inc. | 7468.00 USD | -19458.168% |
| Stratec SE | 289.14 Million USD | 99.495% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Perimeter Medical Imaging AI, Inc. | 403.53 Thousand USD | -261.954% |
| SANUWAVE Health, Inc. | 20.39 Million USD | 92.839% |
| VMS Rehab Systems, Inc. | 71.70 USD | -2037004.603% |
| Guided Therapeutics, Inc. | 98 Thousand USD | -1390.412% |
| Ingen Technologies, Inc. | 720.67 Thousand USD | -102.671% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 2.84 Million USD | 48.665% |
| Urologix, Inc. | 14.23 Million USD | 89.739% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | -Infinity% |
| Nexeon MedSystems Inc. | 3.3 Million USD | 55.776% |
| SS Innovations International, Inc. | 5.87 Million USD | 75.159% |
| Qualis Innovations, Inc. | 40.17 Thousand USD | -3535.604% |
| Smith & Nephew plc | 5.68 Billion USD | 99.974% |
| NIOX Group Plc | 46.84 Million USD | 96.882% |
| Fuse Medical, Inc. | 16.11 Million USD | 90.937% |
| Broncus Holding Corporation | 10.25 Million USD | 85.757% |
| Brain Scientific Inc. | 214.56 Thousand USD | -580.731% |
| Pressure BioSciences, Inc. | 1.97 Million USD | 26.149% |
| Health Logic Interactive Inc. | - USD | -Infinity% |